Citius Pharmaceuticals Inc
CTXR
$0.56+0.02%
End of day · as of Sep 16, 2026, 4:17 PM ET
Mkt cap
$13.41M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$1.49M
EPS (9mo ended 2026-06-30)
$-1.64
Gross Margin (qtr ended 2026-06-30)
67.07%
Profit Margin (qtr ended 2026-06-30)
-797.92%
Beta
0.85
Div yield
N/A
Sector
Healthcare
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Latest reported CTXR revenue for 2026-06-30 was $1.5M. Net income was -$11.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Use this CTXR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CTXR income, balance, and cash tables.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company in the Healthcare sector.
Latest cached Citius Pharmaceuticals Inc (CTXR) revenue for Jun 30, 2026 was $1.5M. Net income was -$11.9M. Statements: https://lician.com/financials/ctxr
Citius Pharmaceuticals Inc (CTXR) market capitalization is $13.4M on the latest cached snapshot.
Citius Pharmaceuticals Inc (CTXR) cached previous close $0.56; day range $0.56 – $0.57; volume 135,686. Session quote: https://lician.com/quote/ctxr
Citius Pharmaceuticals Inc (CTXR) latest cached earnings event is "CTXR earnings" on Aug 18, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CTXR filing is 8-K · Aug 21, 2026. Filings: https://lician.com/sec/ctxr